Blood Transfusion and Donation

+ -Text Size

TOPICS

Previous Topic

To learn more

References

AABB, American Red Cross, America’s Blood Centers, and the Armed Services Blood Program. Circular of Information for the Use of Human Blood and Blood Components. April 2013. Accessed at www.aabb.org/resources/bct/Documents/coi0413.pdf on October 3, 2013.

American Red Cross. Blood Types. Accessed at www.redcrossblood.org/learn-about-blood/blood-types on October 2, 2013.

American Red Cross. Donating Blood: Eligibility Guidelines. Accessed at www.redcrossblood.org/donating-blood/eligibility-requirements on October 2, 2013.

American Red Cross. A Compendium of Transfusion Practice Guidelines. First Edition 2010. Accessed at www.redcrossblood.org/sites/arc/files/pdf/Practice-Guidelines-Nov2010-Final.pdf on October 2, 2013.

American Red Cross. Blood Testing. Accessed at www.redcrossblood.org/learn-about-blood/what-happens-donated-blood/blood-testing on October 2, 2013.

Babic A, Kaufman RM. Principles of platelet transfusion therapy. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, et al, eds. Hematology: Basic Principles and Practice. 5th ed. Philadelphia, Pa: Churchill Livingstone; 2009:2219-2223.

Centers for Disease Control and Prevention. Blood Safety. Accessed at hwww.cdc.gov/bloodsafety/bbp/bacterial-contamination-of-platelets.html on October 3, 2013.

Centers for Disease Control and Prevention. Parasites - American Trypanosomiasis (also known as Chagas Disease): Blood Screening FAQs. Accessed at www.cdc.gov/parasites/chagas/gen_info/screening.html on October 3, 2013.

Chang TM. From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond. Artif Cells Bld Substit Immobil Biotechnol. 2012;40(3):197-99.

Cushing MM, Ness PM. Principles of red blood cell transfusion. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, et al, eds. Hematology: Basic Principles and Practice. 5th ed. Philadelphia, Pa: Churchill Livingstone; 2009:2209-2218.

Dodd RY, Notari EP 4th, Stramer SL for the Transmissible Diseases Department, American Red Cross. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion. 2002;42(8):975-979.

Dodd RY. Current risk for transfusion transmitted infections. Curr Opin Hematol. 2007;14:671-676.

Domen RE. Blood Product Transfusions in the Hematologic Malignancies. In Sekeres MA, Kalaycio ME, Bolwell BJ, eds. Clinical Malignant Hematology. New York: McGraw-Hill; 2007:1127-1138.

Eder A. Blood Donors with a history of cancer. In: Eder A, Bianco C, eds. Screening Blood Donors: Science, Reason, and the Blood Donation Questionnaire. Bethesda, Md: AABB Press: 2007:77-92.

Edgren G, Hjalgrim H, Reilly M, et al. Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet. 2007;369:1724-1730.

Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for Industry: An Acceptable Circular of Information for the Use of Human Blood and Blood Components. Updated August 2013. Accessed at www.fda.gov/downloads/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/blood/ucm364593.pdf on October 3, 2013.

Food and Drug Administration, FDA News Release. FDA Clears for Marketing First Rapid Test to Screen for Bacterial Contamination in Blood Platelets. Accessed at www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108986.htm on October 3, 2013.

Glaspy J. Disorders of blood cell production in clinical oncology. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, eds. Abeloff’s Clinical Oncology. 4th ed. Philadelphia, Pa: Churchill Livingstone; 2008:677-692.

Hay SN, Scanga L, Brecher ME. Life, death, and the risk of transfusion: a university hospital experience. Transfusion. 2006;46(9):1491-1493.

Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesth Analg. 2009;108(3):759-769.

Henkel-Honke T, Oleck M. Artificial oxygen carriers: a current review. AANA J. 2007;75:205-211.

Higgins MJ, Blackall DP. Transfusion-associated graft-versus-host disease: a serious residual risk of blood transfusion. Curr Hematol Rep. 2005;4:470-476.

Hjalgrim H, Edgren G, Rostgaard K, et al. Cancer Incidence in Blood Transfusion Recipients. J Natl Cancer Inst. 2007;99:1864-1874.

Jaworski K, Maslanka K, Kosior DA. Transfusion-related acute lung injury: A dangerous and underdiagnosed noncardiogenic pulmonary edema. Cardiology Journal. 2013;20(4):337-344.

Marik PE. The hazards of blood transfusion. British Journal of Hospital Medicine. 2009;70(1):12-15.

Marik PE, Corwin HL. Acute lung injury following blood transfusion: expanding the definition. Crit Care Med. 2008;36(11):3080-3084.

Morris-Stiff G, Steel A, Savage P, et al. Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant. 2004;4:444-446.

Silliman CC. Transfusion-related acute lung injury (TRALI), in Hematology 2004, American Society of Hematology; 2004: 461-466. Accessed at www.asheducationbook.org on June 19, 2009. Content no longer available.

Triulzi DJ. Transfusion-related acute lung injury: an update. Hematology Am Soc Hematol Educ Program. 2006:497-501.

Vandegriff KD, Winslow RM. Hemospan: design principles for a new class of oxygen therapeutic. Artif Organs. 2009;33(2):133-138.

Yang H, Lee J, Seed CR, Keller AJ. Can blood tranfusion transmit cancer? A literature review. Transfus Med Rev. 2010;24(3):235-243.


Last Medical Review: 10/07/2013
Last Revised: 10/07/2013